AD progression is characterized by the concurrence of different pathological events occurring in parallel, such as Aβ aggregation, tau hyperphosphorylation and oligomerization, synaptic dysfunctions, and inflammation. The gene discussed is MAPT; the disease is Alzheimer disease.